-
Je něco špatně v tomto záznamu ?
Functional analysis of germline ETV6 W380R mutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia
KS. Kozubik, L. Radova, K. Reblova, M. Smida, M. Zaliova Kubricanova, J. Baloun, M. Pesova, Z. Vrzalova, F. Folber, S. Mejstrikova, S. Pospisilova, M. Doubek
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
Medline Complete (EBSCOhost)
od 1999-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1990
- MeSH
- akutní lymfatická leukemie genetika MeSH
- esenciální trombocytemie genetika MeSH
- lidé MeSH
- protoonkogenní proteiny c-ets metabolismus MeSH
- represorové proteiny metabolismus MeSH
- trombocytopenie metabolismus MeSH
- zárodečné mutace genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Germline mutations in ETV6 gene cause inherited thrombocytopenia with leukemia predisposition. Here, we report on functional validation of ETV6 W380R mutation segregating with thrombocytopenia in a family where two family members also suffered from acute lymphoblastic leukemia (ALL) or essential thrombocythemia (ET). In-silico analysis predicted impaired DNA binding due to W380R mutation. Functional analysis showed that this mutation prevents the ETV6 protein from localizing into the cell nucleus and impairs the transcriptional repression activity of ETV6. Based on the germline ETV6 mutation, ET probably started with somatic JAK2 V617F mutation, whereas ALL could be caused by diverse mechanisms: high-hyperdiploidity; somatic deletion of exon 1 IKZF1 gene; or somatic mutations of other genes found by exome sequencing of the ALL sample taken at the diagnosis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003918
- 003
- CZ-PrNML
- 005
- 20220127145727.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/09537104.2020.1802416 $2 doi
- 035 __
- $a (PubMed)32819174
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kozubik, Katerina Stano $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 245 10
- $a Functional analysis of germline ETV6 W380R mutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia / $c KS. Kozubik, L. Radova, K. Reblova, M. Smida, M. Zaliova Kubricanova, J. Baloun, M. Pesova, Z. Vrzalova, F. Folber, S. Mejstrikova, S. Pospisilova, M. Doubek
- 520 9_
- $a Germline mutations in ETV6 gene cause inherited thrombocytopenia with leukemia predisposition. Here, we report on functional validation of ETV6 W380R mutation segregating with thrombocytopenia in a family where two family members also suffered from acute lymphoblastic leukemia (ALL) or essential thrombocythemia (ET). In-silico analysis predicted impaired DNA binding due to W380R mutation. Functional analysis showed that this mutation prevents the ETV6 protein from localizing into the cell nucleus and impairs the transcriptional repression activity of ETV6. Based on the germline ETV6 mutation, ET probably started with somatic JAK2 V617F mutation, whereas ALL could be caused by diverse mechanisms: high-hyperdiploidity; somatic deletion of exon 1 IKZF1 gene; or somatic mutations of other genes found by exome sequencing of the ALL sample taken at the diagnosis.
- 650 _2
- $a zárodečné mutace $x genetika $7 D018095
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní lymfatická leukemie $x genetika $7 D054198
- 650 _2
- $a protoonkogenní proteiny c-ets $x metabolismus $7 D050783
- 650 _2
- $a represorové proteiny $x metabolismus $7 D012097
- 650 _2
- $a esenciální trombocytemie $x genetika $7 D013920
- 650 _2
- $a trombocytopenie $x metabolismus $7 D013921
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Radova, Lenka $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic
- 700 1_
- $a Reblova, Kamila $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Smida, Michal $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Zaliova Kubricanova, Marketa $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Baloun, Jiri $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic
- 700 1_
- $a Pesova, Michaela $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Vrzalova, Zuzana $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic
- 700 1_
- $a Folber, Frantisek $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Mejstrikova, Sona $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Pospisilova, Sarka $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Doubek, Michael $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic $u Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00005009 $t Platelets $x 1369-1635 $g Roč. 32, č. 6 (2021), s. 838-841
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32819174 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145723 $b ABA008
- 999 __
- $a ok $b bmc $g 1751395 $s 1155067
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 32 $c 6 $d 838-841 $e 20200821 $i 1369-1635 $m Platelets $n Platelets $x MED00005009
- LZP __
- $a Pubmed-20220113